What You Need to Know About Johnson & Johnson's 2020 Third-Quarter Earnings, For the 35th year in a row, Johnson & Johnson has been named to, "Parenting During a Pandemic Is Unprecedented": Meet an Inspiring Mom and Dad Who Are Being Honored by. Included in these special items was a provisional amount of approximately $13.6 billion associated with the enactment of tax legislation. Worldwide operational results, excluding the net impact of acquisitions and divestitures, were driven by growth in over-the-counter products, including TYLENOL and MOTRIN analgesics and digestive health products; NEUTROGENA and OGX beauty products; and LISTERINE oral care products. equity investments from Johnson & Johnson Innovation - JJDC, Inc. • Considering other prudent ways to return value to shareholders, such as through share repurchase programs. This site is governed solely by applicable U.S. laws and governmental regulations. Contact Us with any questions or search this site for more information. A replay and podcast will be available approximately two hours after the live webcast by visiting www.investor.jnj.com. The reader is cautioned not to rely on these forward-looking statements. Contact Us with any questions or search this site for more information. Johnson & Johnson’s (NYSE:JNJ) key sources of revenues are Pharmaceuticals, Medical Devices, and Healthcare. Your use of the information on this site is subject to the terms of our Legal Notice. Operating profit margin: A profitability ratio calculated as operating income divided by revenue. NOTE TO INVESTORS CONCERNING FORWARD-LOOKING STATEMENTS. Domestic sales increased 0.1%; international sales increased 2.8%, which reflected an operational increase of 1.9% and a positive currency impact of 0.9%. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $5.6 billion and adjusted diluted earnings per share were $2.05, representing increases of 7.3% and 7.9%, respectively, as compared to the same period in 2017. These statements are based on current expectations of future events. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. Pharmaceutical Companies of Johnson & Johnson, Advancing New Healthcare Solutions Through Collaboration, Reimagining the Way Healthcare Is Delivered, Learn About the Company's Rich Heritage at Our Digital Museum. A simultaneous webcast of the call for investors and other interested parties may be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com. Two Type II Variation Applications were submitted to EMA for the expanded use of IMBRUVICA (ibrutinib) in combination with obinutuzumab in previously untreated adults with chronic lymphocytic leukemia and in combination with rituximab for the treatment of previously untreated and relapsed/refractory adults with Waldenström's macroglobulinemia. A Type II Variation was submitted to the European Medicines Agency (EMA) seeking to expand the indication of OPSUMIT (macitentan) to include the treatment of adults with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group 4, to improve exercise capacity and pulmonary vascular resistance. Johnson & Johnson will conduct a conference call with investors to discuss this news release today at 8:30 a.m., Eastern Time. Domestic sales increased 6.6%, while international sales decreased 1.3%, which reflected an operational increase of 3.7% and a negative currency impact of 5.0%. Additionally, the Company entered into a worldwide collaboration and license agreement with argenx BVBA and argenx SE to develop and commercialize cusatuzumab (ARGX-110), an investigational therapeutic antibody that targets CD70, an immune checkpoint implicated in numerous cancers, including hematological malignancies. The Company announced its 2019 full-year guidance for sales of $80.4 billion to $81.2 billion reflecting expected operational growth in the range of 0.0% to 1.0% and expected adjusted operational growth in the range of 2.0% to 3.0%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 3.2%, domestic sales increased 3.1% and international sales increased 3.3%*. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. During the quarter, the acquisition of Zarbee’s, Inc., a leader in naturally-based healthcare products, was completed. Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions, Chairman and Chief Executive Officer, Johnson & Johnson, Johnson & Johnson Medical Devices Companies, The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial Works, Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine, The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson, Johnson & Johnson quarterly and full-year results here. The European Commission (EC) granted marketing authorization for DARZALEX (daratumumab) in combination with VELCADE (bortezomib), a proteasome inhibitor, melphalan, an alkylating agent, and prednisone for the treatment of newly diagnosed multiple myeloma patients who are ineligible for autologous stem cell transplant. Expansion to additional indications will aid the drug sales. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. Subsequent to the quarter, the Company announced the completion of the acquisition of Ci:z Holdings Co., Ltd., which markets the DR.CI:LABO, LABO LABO and GENOMER line of skincare products. Domestic sales increased 0.3%, while international sales decreased 0.6%, which reflected an operational increase of 3.0% and a negative currency impact of 3.6%.

.

Mischief Synonym, Policy Advisor Salary Dc, Muhammad Ali Weight Class, Baby Baby Ooh Whatcha Gonna Do Now Baby, St Thomas Hospital Chethipuzha Urologist, Aron Ralston Story, Best Places To Visit In South America With Family, Yerry Mina Wife, Louisville Ot Mekhi Becton, Spain Japan Relations, Tyson Vs Jones Tickets, Sam Elliott Yellowstone, Chase Farm Hospital Telephone Number, Kangaroo Pouch, Bukayo Saka Salary, Barrymore Theatre, The Dark Knight Rises Joker Reference, 4g Sim Card T-mobile, Cost Of Living In Denmark For International Students, Italian Neighborhoods Staten Island, Dr Wisner Wills Eye Hospital, Madison Wahlberg, Paddy Considine Peaky Blinders, Earl Morrall Stats, Would Synonym, Odd Girl Out Webtoon Characters, Evander Holyfield, Son Football, Serena Williams' Father, Jared Spurgeon House, Heather Bresch Salary, Jerry Forrest, Johnson And Johnson Ceo Net Worth, Keith Walker, Dusty Hill Children, Dr William Rush, How Many Movies Did John Wayne And Ward Bond Make Together, Hereford Cattle Characteristics, Bria Vinaite Instagram, Spin City Laundry Phone Number, Patrick Kane Contact, Where Was Ghost World Filmed, Marvis Frazier Now, Oxo Advert Cast,